Iart L. Shytaj

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV.

Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV.

Journal: The Journal of infectious diseases
Published: May 12, 2025

Fast pH-Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medicinal Purposes.

Fast pH-Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medicinal Purposes.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 12, 2025

A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening.

A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening.

Journal: Viruses
Published: February 11, 2025

Aquarius helicase facilitates HIV-1 integration into R-loop enriched genomic regions.

Aquarius helicase facilitates HIV-1 integration into R-loop enriched genomic regions.

Journal: Nature microbiology
Published: June 05, 2024

Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.

Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.

Journal: Antiviral research
Published: August 23, 2023

A scalable workflow to test "shock and kill" therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo.

A scalable workflow to test "shock and kill" therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo.

Journal: STAR protocols
Published: January 15, 2023

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.

Journal: Therapeutic advances in respiratory disease
Published: October 25, 2022

Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains.

Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains.

Journal: Cell reports
Published: June 09, 2022

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters.

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters.

Journal: mBio
Published: March 01, 2022

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.

Journal: AIDS research and therapy
Published: September 07, 2021

Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress.

Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress.

Journal: EMBO molecular medicine
Published: January 03, 2021

Patient-Derived HIV-1 Nef Alleles Reveal Uncoupling of CD4 Downregulation and SERINC5 Antagonism Functions of the Viral Pathogenesis Factor.

Patient-Derived HIV-1 Nef Alleles Reveal Uncoupling of CD4 Downregulation and SERINC5 Antagonism Functions of the Viral Pathogenesis Factor.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 17, 2020
Showing 1-12 of 23

Last Updated: 09/26/2026